MDS to Present at the Scotia Capital Pharmaceutical & Biotechnology Conference
25 Aprile 2006 - 3:00PM
PR Newswire (US)
TORONTO, April 25 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS;
NYSE: MDZ), a global company providing a range of enabling products
and services to the global life sciences markets, announced that
Stephen DeFalco, President and Chief Executive Officer, will
present at the Scotia Capital Pharmaceutical & Biotechnology
Conference on Wednesday, April 26th at 11:40 am (ET). Interested
parties may access the live webcast by visiting the "Latest News"
section of the homepage at http://www.mdsinc.com/. An audio archive
of the presentation will be available under Webcasts &
Presentations in our "For Investors" section until May 26, 2006.
MDS Inc. has more than 8,800 highly skilled people in 27 countries.
We provide a diverse range of superior products and services to
increase our customers' speed, precision and productivity in the
drug development and disease diagnosis processes. We are a global,
values-driven life sciences company, recognized for our reliability
and collaborative relationships as we help create better outcomes
in the treatment of disease. Find out more at
http://www.mdsinc.com/ or by calling 1-800-MDS-7222, 24 hours a
day. DATASOURCE: MDS Inc. CONTACT: Sharon Mathers, Vice-President,
Investor Relations and External Communications, (416) 675-6777 x
4721,
Copyright